by Annie De Groot | Jun 8, 2020 | Featured, News
PROVIDENCE, RI, June 8, 2020 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) a Rhode Island-based company and recognized leader in the field in the field of immunogenicity assessment today announced it has licensed its advanced in silico toolkit for biologics...
by Annie De Groot | Jun 2, 2020 | Featured, News
Bilthoven, The Netherlands, Providence, R.I., USA, 2 June 2020 – Intravacc, one of the world’s leading translational research and development vaccine institutes, with an extensive track record in developing viral and bacterial vaccines, and EpiVax, a...
by Annie De Groot | May 12, 2020 | Thinking Out Loud -Blog
Pepcid: From Poor Man’s Cure to $20M COVID-19 Trial Remember Hydrocychloroquine? The drug that doesn’t work for COVID-19? Well, here’s some good news for you. A crazy rock climber/mountain rescue nut named Michael Callahan and a brilliant group of...
by Annie De Groot | May 1, 2020 | Events, Webinars
This webinar has passed but we invite you to view the recording below. Please extend this invitation to any colleagues or associates you feel would benefit from attending. Participation is always free and open to all. We look forward to “seeing” you...
by Annie De Groot | May 1, 2020 | Featured, News
HONG KONG, May 1, 2020 (Newswire.com) – Pacific GeneTech (PGT), a biologics company that develops and commercializes next-generation vaccines for areas of high unmet or underserved needs in animal health and food safety, is collaborating with Rhode Island-based...